| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.018 | 0.9 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | 0.016 | 0.9 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.016 | 0.9 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |